Khowailed Akef, Younan Sandra Mourad, Ashour Hend, Kamel Abd Elkarim, Sharawy Nivin
Department of Physiology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Department of Biochemistry, Faculty of Medicine, Cairo University, Cairo, Egypt.
Clin Exp Nephrol. 2015 Jun;19(3):419-26. doi: 10.1007/s10157-014-1006-x. Epub 2014 Jul 8.
BACKGROUND: Among the several disorders induced by sepsis, acute kidney injury (AKI) represents the most important economic burden problem that is associated with high mortality and morbidity rates. The aim of this study was to investigate the anti-inflammatory effects of ghrelin in sepsis-induced AKI and the possible role of vagus nerve. METHODS: Five groups were included: sham, cecal ligation and puncture (CLP), CLP-ghrelin, CLP-vagotomy and CLP-vagotomy-ghrelin group. RESULTS: Ghrelin treatment immediately after induction of CLP, significantly improved renal Glomerular filtration rate (GFR), serum creatinine, BUN and renal necrosis score as compared to the unprotected CLP group. In addition, ghrelin significantly decreased renal TNF alpha (111.5 ± 10.35 vs. 291.8 ± 15.8 pg/mg ptn), VCAM1 (6.28 ± 1.7 vs. 12.9 ± 1.2 µ/g ptn) and MPO (0.95 ± 0.13 vs. 2.5 ± 0.4 µ/g ptn) without significant increase in renal IL-10. Those effects were abolished by vagotomy. CONCLUSION: We concluded that ghrelin could represent new therapeutic window in early treatment of sepsis-induced AKI and this could be mainly due to its anti-inflammatory effects.
背景:在脓毒症引发的多种病症中,急性肾损伤(AKI)是最重要的经济负担问题,与高死亡率和发病率相关。本研究旨在探讨胃饥饿素在脓毒症诱导的急性肾损伤中的抗炎作用以及迷走神经的可能作用。 方法:共纳入五组:假手术组、盲肠结扎穿孔(CLP)组、CLP-胃饥饿素组、CLP-迷走神经切断术组和CLP-迷走神经切断术-胃饥饿素组。 结果:与未给予保护的CLP组相比,CLP诱导后立即给予胃饥饿素治疗可显著改善肾肾小球滤过率(GFR)、血清肌酐、血尿素氮和肾坏死评分。此外,胃饥饿素可显著降低肾肿瘤坏死因子α(111.5±10.35对291.8±15.8 pg/mg蛋白)、血管细胞黏附分子1(6.28±1.7对12.9±1.2 µ/g蛋白)和髓过氧化物酶(0.95±0.13对2.5±0.4 µ/g蛋白),而肾白细胞介素-10无显著升高。迷走神经切断术可消除这些作用。 结论:我们得出结论,胃饥饿素可能是脓毒症诱导的急性肾损伤早期治疗的新治疗窗口,这可能主要归因于其抗炎作用。
Clin Exp Nephrol. 2015-6
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022-11
Nephrology (Carlton). 2024-10
Med Sci Monit. 2019-1-5
Am J Physiol Renal Physiol. 2014-10-15
Mol Biol Rep. 2023-12
Front Immunol. 2020
Int J Endocrinol. 2020-5-25
Turk J Med Sci. 2019-4-18
Inflammation. 2018-10
Int J Mol Sci. 2017-4-11
J Clin Invest. 2012-10-24
J Surg Res. 2012-3-10
J Am Soc Nephrol. 2011-5-12
World J Diabetes. 2011-1-15
Mediators Inflamm. 2010-2-21
Am J Physiol Renal Physiol. 2009-10